Search

Your search keyword '"Sanguineti G"' showing total 28 results
Start Over Author "Sanguineti G" Publisher elsevier ireland ltd
28 results on '"Sanguineti G"'

26. Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study

Author

Vittorio Vavassori, Elisabetta Garibaldi, Giuseppe Girelli, S. Aimonetto, Tiziana Rancati, Carla Sini, Letizia Ferella, Valeria Landoni, Elisa Villa, Giuseppe Sanguineti, Fernando Munoz, Claudio Fiorino, Alessandro Magli, Barbara Avuzzi, Nadia Di Muzio, Riccardo Valdagni, A. Faiella, Domenico Cante, Cesare Cozzarini, Marco Gatti, A. Bresolin, Angelo Maggio, Barbara Noris Chiorda, J.M. Waskiewicz, Bresolin, A., Faiella, A., Garibaldi, E., Munoz, F., Cante, D., Vavassori, V., Waskiewicz, J. M., Girelli, G., Avuzzi, B., Villa, E., Magli, A., Noris Chiorda, B., Gatti, M., Ferella, L., Maggio, A., Landoni, V., Aimonetto, S., Sini, C., Rancati, T., Sanguineti, G., Valdagni, R., Di Muzio, N., Fiorino, C., and Cozzarini, C.

Subjects
Diarrhea, Male, Percentile, medicine.medical_specialty, medicine.medical_treatment, Dose-volume effect, Inflammatory bowel disease, 030218 nuclear medicine & medical imaging, Pelvis, Predictive models, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Patient Reported Outcome Measures, Prospective Studies, business.industry, Area under the curve, Prostatic Neoplasms, Radiotherapy Dosage, Hematology, medicine.disease, Radiation therapy, Oncology, 030220 oncology & carcinogenesis, Toxicity, Acute bowel toxicity, Radiology, Radiotherapy, Intensity-Modulated, medicine.symptom, business, Cohort study
Abstract

Background and purpose: To assess bowel dose-volume relationships for acute patient-reported intestinal symptoms of patients treated with whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. Materials and methods: Complete data of 415 patients enrolled in a multi institute, prospective trial (#NCT02803086) treated with radical (31%), adjuvant (33%) and salvage (36%) intent at a median dose to pelvic nodes/lymph-nodal area of 53 Gy were available. The most severe changes between baseline and radiotherapy mid-point/end toxicity assessed by Inflammatory Bowel Disease Questionnaire (only Bowel Domain) were considered (ΔIBDQ). The 25th percentile values of these score variations were set as endpoints. DVHs of bowel loops for patients with/without toxicity were compared for each endpoint, having excluded patients with baseline scores

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results